UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 67

Sortiert nach

Insight into the truffle brûlé: tripartite interactions between the black truffle (Tuber melanosporum), holm oak (Quercus ilex) and arbuscular mycorrhizal plants

Plant and soil, 2020, Vol.446 (1-2), p.577-594

2020

Volltextzugriff (PDF)

Insight into the truffle brûlé: tripartite interactions between the black truffle (Tuber melanosporum), holm oak (Quercus ilex) and arbuscular mycorrhizal plants

Plant and soil, 2020-01, Vol.446 (1-2), p.577-594

2020

Volltextzugriff (PDF)

Low-pressure versus standard pressure laparoscopic colorectal surgery (PAROS trial): a phase III randomized controlled trial

British journal of surgery, 2021-08, Vol.108 (8), p.998-1005

2021

Volltextzugriff (PDF)

Clinical utility of circulating DNA analysis for rapid detection of actionable mutations to select metastatic colorectal patients for anti-EGFR treatment

Annals of oncology, 2017-09, Vol.28 (9), p.2149-2159

2017

Volltextzugriff (PDF)

Efficacy and safety of selective internal radiotherapy with yttrium-90 resin microspheres compared with sorafenib in locally advanced and inoperable hepatocellular carcinoma (SARAH): an open-label randomised controlled phase 3 trial

The lancet oncology, 2017-12, Vol.18 (12), p.1624-1636

2017

Volltextzugriff (PDF)

FOLFIRINOX versus Gemcitabine for Metastatic Pancreatic Cancer

The New England journal of medicine, 2011-05, Vol.364 (19), p.1817-1825

2011

Volltextzugriff (PDF)

Intersphincteric resection for low rectal cancer: the risk is functional rather than oncological. A 25‐year experience from Bordeaux

Colorectal disease, 2020-11, Vol.22 (11), p.1603-1613

2020

Volltextzugriff (PDF)

MR volumetric measurement of low rectal cancer helps predict tumor response and outcome after combined chemotherapy and radiation therapy

Radiology, 2012-05, Vol.263 (2), p.409

2012

Volltextzugriff (PDF)

Atezolizumab plus Bevacizumab in Unresectable Hepatocellular Carcinoma

The New England journal of medicine, 2020-05, Vol.382 (20), p.1894-1905

2020

Volltextzugriff (PDF)

Tacrolimus and the Risk of Solid Cancers After Liver Transplant: A Dose Effect Relationship

American journal of transplantation, 2015-03, Vol.15 (3), p.678-686

2015

Volltextzugriff (PDF)

FOLFIRINOX or Gemcitabine as Adjuvant Therapy for Pancreatic Cancer

The New England journal of medicine, 2018-12, Vol.379 (25), p.2395-2406

2018

Volltextzugriff (PDF)

Development and validation of AI-assisted transcriptomic signatures to personalize adjuvant chemotherapy in patients with pancreatic ductal adenocarcinoma

Annals of oncology, 2024-06

2024

Volltextzugriff (PDF)

Effect of everolimus on survival in advanced hepatocellular carcinoma after failure of sorafenib: the EVOLVE-1 randomized clinical trial

JAMA : the journal of the American Medical Association, 2014-07, Vol.312 (1), p.57

2014

Volltextzugriff (PDF)

Treatment techniques for rectovaginal fistulas after low rectal resection for deep endometriosis

Techniques in coloproctology, 2024-12, Vol.28 (1), p.51-51, Article 51

2024

Volltextzugriff (PDF)

Effect of ramucirumab on ALBI grade in patients with advanced HCC: Results from REACH and REACH-2

JHEP reports, 2021-04, Vol.3 (2), p.100215-100215, Article 100215

2021

Volltextzugriff (PDF)

121P PemiBil: Efficacy and safety of pemigatinib in advanced cholangiocarcinoma with FGFR2 fusions/rearrangements in real-world, results of multicentric French cohort from ACABI consortium

Annals of oncology, 2023-10, Vol.34, p.S228-S228

2023

Volltextzugriff (PDF)

UCGI 28 Panirinox: A randomized phase II study assessing Panitumumab + FOLFIRINOX or mFOLFOX6 in RAS and BRAF wild type metastatic colorectal cancer patients (mCRC) selected from circulating DNA analysis

Annals of oncology, 2018-10, Vol.29, p.viii204-viii204

2018

Volltextzugriff (PDF)

O029 : HCV triggers Wnt paracrine signalling that modulates metabolic liver zonation

Journal of hepatology, 2015-04, Vol.62, p.S204-S204

2015

Volltextzugriff (PDF)

936P Effects of tislelizumab (TIS) monotherapy on health-related quality of life in patients with previously treated unresectable hepatocellular carcinoma (HCC)

Annals of oncology, 2021-09, Vol.32, p.S821-S821

2021

Volltextzugriff (PDF)

Four-year overall survival update from the phase III HIMALAYA study of tremelimumab plus durvalumab in unresectable hepatocellular carcinoma

Annals of oncology, 2024-05, Vol.35 (5), p.448-457

2024

Volltextzugriff (PDF)

Lean body mass as an independent determinant of dose‐limiting toxicity and neuropathy in patients with colon cancer treated with FOLFOX regimens

Cancer medicine (Malden, MA), 2016-04, Vol.5 (4), p.607-616

2016

Volltextzugriff (PDF)

P-19 Subgroup analysis of the number of prior lines of systemic therapy and clinical outcomes associated with tislelizumab in patients with previously treated advanced hepatocellular carcinoma (HCC)

Annals of oncology, 2022-06, Vol.33, p.S253

2022

Volltextzugriff (PDF)

Phase II trial to evaluate efficacy and tolerance of regorafenib monotherapy in patients (pts) over 70 with previously treated metastatic colorectal adenocarcinoma (mCRC) FFCD 1404 - REGOLD

Annals of oncology, 2018-10, Vol.29 Suppl 8, p.viii156

2018

Volltextzugriff (PDF)

1 – 25 von 67

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(56)
Mit Volltextzugriff
(57)

Publikationsform

Artikel
(67)

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(26)
Humans
(25)
Life Sciences & Biomedicine
(24)
Female
(21)
Male
(20)
Middle Aged
(18)
Aged
(16)
Life Sciences
(15)
Adult
(14)
Cancer
(9)
Liver Neoplasms - Drug Therapy
(8)
Carcinoma, Hepatocellular - Drug Therapy
(7)
Treatment Outcome
(7)
Tumors
(7)
Clinical Trials
(6)
Gastroenterology & Hepatology
(6)
Oncology
(6)
Surgery
(6)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(5)
Biological And Medical Sciences
(5)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Insight into the truffle brûlé: tripartite interactions between the black truffle (Tuber melanosporum), holm oak (Quercus ilex) and arbuscular mycorrhizal plants

Insight into the truffle brûlé: tripartite interactions between the black truffle (Tuber melanosporum), holm oak (Quercus ilex) and arbuscular mycorrhizal plants

Low-pressure versus standard pressure laparoscopic colorectal surgery (PAROS trial): a phase III randomized controlled trial

Clinical utility of circulating DNA analysis for rapid detection of actionable mutations to select metastatic colorectal patients for anti-EGFR treatment

Efficacy and safety of selective internal radiotherapy with yttrium-90 resin microspheres compared with sorafenib in locally advanced and inoperable hepatocellular carcinoma (SARAH): an open-label randomised controlled phase 3 trial

FOLFIRINOX versus Gemcitabine for Metastatic Pancreatic Cancer

Intersphincteric resection for low rectal cancer: the risk is functional rather than oncological. A 25‐year experience from Bordeaux

Nivolumab versus sorafenib in advanced hepatocellular carcinoma (CheckMate 459): a randomised, multicentre, open-label, phase 3 trial

MR volumetric measurement of low rectal cancer helps predict tumor response and outcome after combined chemotherapy and radiation therapy

Atezolizumab plus Bevacizumab in Unresectable Hepatocellular Carcinoma

Ramucirumab after sorafenib in patients with advanced hepatocellular carcinoma and increased α-fetoprotein concentrations (REACH-2): a randomised, double-blind, placebo-controlled, phase 3 trial

Tacrolimus and the Risk of Solid Cancers After Liver Transplant: A Dose Effect Relationship

FOLFIRINOX or Gemcitabine as Adjuvant Therapy for Pancreatic Cancer

Development and validation of AI-assisted transcriptomic signatures to personalize adjuvant chemotherapy in patients with pancreatic ductal adenocarcinoma

Effect of everolimus on survival in advanced hepatocellular carcinoma after failure of sorafenib: the EVOLVE-1 randomized clinical trial

Treatment techniques for rectovaginal fistulas after low rectal resection for deep endometriosis

Effect of ramucirumab on ALBI grade in patients with advanced HCC: Results from REACH and REACH-2

121P PemiBil: Efficacy and safety of pemigatinib in advanced cholangiocarcinoma with FGFR2 fusions/rearrangements in real-world, results of multicentric French cohort from ACABI consortium

UCGI 28 Panirinox: A randomized phase II study assessing Panitumumab + FOLFIRINOX or mFOLFOX6 in RAS and BRAF wild type metastatic colorectal cancer patients (mCRC) selected from circulating DNA analysis

O029 : HCV triggers Wnt paracrine signalling that modulates metabolic liver zonation

936P Effects of tislelizumab (TIS) monotherapy on health-related quality of life in patients with previously treated unresectable hepatocellular carcinoma (HCC)

Four-year overall survival update from the phase III HIMALAYA study of tremelimumab plus durvalumab in unresectable hepatocellular carcinoma

Lean body mass as an independent determinant of dose‐limiting toxicity and neuropathy in patients with colon cancer treated with FOLFOX regimens

P-19 Subgroup analysis of the number of prior lines of systemic therapy and clinical outcomes associated with tislelizumab in patients with previously treated advanced hepatocellular carcinoma (HCC)

Phase II trial to evaluate efficacy and tolerance of regorafenib monotherapy in patients (pts) over 70 with previously treated metastatic colorectal adenocarcinoma (mCRC) FFCD 1404 - REGOLD

Suchergebnisse filtern